首页> 外文期刊>Multidisciplinary Respiratory Medicine >Baseline characteristics and outcomes of COVID-19 patients admitted to a Respiratory Intensive Care Unit (RICU) in Southern Italy
【24h】

Baseline characteristics and outcomes of COVID-19 patients admitted to a Respiratory Intensive Care Unit (RICU) in Southern Italy

机译:Covid-19患者的基线特征和结果,入住意大利南部呼吸密集型护理单位(RICU)

获取原文
获取外文期刊封面目录资料

摘要

The recent Coronavirus disease 19 (COVID-19) pandemic, first in China and then also in Italy, brought to the attention the problem of the saturation of Intensive Care Units (ICUs). Almost all previous reports showed that in ICU less than half of patients were treated with invasive mechanical ventilation (IMV) and the rest of them with non-invasive respiratory support. This highlighted the role of respiratory intensive care units (RICUs), where patients with moderate to severe respiratory failure can be treated with non-invasive respiratory support, avoiding ICU admission. In this report, we describe baseline characteristics and clinical outcomes of 97 patients with moderate to severe respiratory failure due to COVID-19 admitted to the RICU of the Policlinico of Bari from March 11th to May 31st 2020. In our population, most of the subjects were male (72%), non-smokers (76%), with a mean age of 69.65±14 years. Ninety-one percent of patients presented at least one comorbidity and 60% had more than two comorbidities. At admission, 40% of patients showed PaO2/FiO2 ratio between 100 and 200 and 17% showed Pa02/FiO2 ratio 100. Mean Pa02/FiO2 ratio at admission was 186.4±80. These patients were treated with non-invasive respiratory support 40% with CPAP, 38% with BPAP, 3% with HFNC, 11% with standard oxygen therapy or with IMV through tracheostomy (patients in step down from ICU, 8%). Patients discharged to general ward (GW) were 51%, 30% was transferred to ICU and 19% died.?To the best of our knowledge, this is one of the few described experiences of patients with respiratory failure due to COVID-19 treated outside the ICU, in a RICU. Outcomes of our patients, characterized by several risk factors for disease progression, were satisfactory compared with other experiences regarding patients treated with non-invasive respiratory support in ICU. The strategical allocation of our RICU, between ED and ICU, might have positively influenced clinical outcomes of our patients.
机译:最近的冠状病毒病19(Covid-19)大流行,在中国,也在意大利,引起了重症监护单位(ICU)饱和的问题。几乎所有先前的报道都显示,在ICU不到一半的患者中,用侵入式机械通气(IMV)和其余的患者用无侵入性呼吸载体治疗。这突出了呼吸密集护理单位(RICus)的作用,其中患有中度至严重呼吸衰竭的患者可以用无侵入性呼吸障碍治疗,避免ICU入院。在本报告中,由于Covid-19从3月11日到2020年3月31日,我们介绍了由于Covid-19的中度至严重呼吸衰竭患者的基线特征和临床结果。在2020年至5月31日,我们的人口大多数受试者男性(72%),非吸烟者(76%),平均年龄为69.65±14岁。百分之九十一患者呈现至少一种合并症,60%有两个以上的合并症。在入院时,40%的患者显示Pao2 / FiO 2的比例100至200%,17%显示PA02 / FiO 2比例<100。入学的平均pA02 / fiO2比例为186.4±80。将这些患者用无侵袭性呼吸载体支撑40%用CPAP治疗,38%用BPAP,3%用HFNC,11%用标准氧疗法或IMV通过气管造口术(患者从ICU下降,8%)。向普通病房(GW)排放的患者分为51%,30%被转移到ICU,19%的人死亡,我们所知的最佳知识,这是由于Covid-19治疗的呼吸失败患者的少数少数患者之一在ICU外,在RICU。我们患者的结果,其特征在于疾病进展的几个危险因素,与ICU中非侵入性呼吸助障人士治疗的患者相比,令人满意。 ED和ICU之间的RICU战略配置可能会对患者的临床结果产生积极影响。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号